Phospho-JUNB (S79) Antibody

1. It has been shown that the AP-1 family member JunB and retinoic acid receptor alpha (RARa) mediate catalase transcriptional activation and repression, respectively, by controlling chromatin remodeling through a histone deacetylases-dependent mechanism. PMID:27591797
2. JunB neddylation mediated by Itch promotes its ubiquitination-dependent degradation. PMID:27245101
3. a specific role for AP-1/JunB in multiple myeloma cell proliferation, survival and drug resistance. PMID:27890927
4. VEGF-induced endothelial migration is mediated primarily by induction of JunB whereas the promotion of endothelial proliferation by VEGF is mediated by JunB-independent AP-1 family members. PMID:26860974
5. Results suggested that JunB could play an important role in promoting cell invasion, migration and distant metastasis in head and neck squamous cell carcinoma via pathways other than epithelial-to-mesenchymal transition. PMID:26754630
6. Highly recurrent mutation of JUNB is associated with nodular lymphocyte predominant Hodgkin lymphoma. PMID:26658840
7. ETS2, HNF4A and JUNB are synergistic master regulators of epithelial-to-mesenchymal transition in cancer. PMID:26926107
8. PDK1 functions as a tumor promoter in human gallbladder cancer by upregulating JunB, promoting epithelial mesenchymal transformation, and cell migration. PMID:26318166
9. Our findings demonstrate that miRNA-149* may serve as an oncogenic regulator in T-cell acute lymphoblastic leukemia by negatively regulating JunB PMID:26725775
10. The MAPK pathway plays a primary role in the control of JUNB gene expression. PMID:25662951
11. JunB is likely to be a key target of c-Abl in expression of p21 in Adriamycin-induced DDR. PMID:26217035
12. Caveolin 2 disengages repressed Egr-1 and JunB promoters from lamin A/C through disassembly of H3K9me3 in the inner nuclear membrane. PMID:25753664
13. JunB expression was significantly increased while cyclin-D1 expression was significantly down-regulated in pre-eclampsia relative to control placental mesenchymal stromal cells. PMID:24780198
14. findings uncover the oncogenic role of the JUNB/CD30 axis and its potential as therapeutic target in ALK+ ALCL. PMID:25145835
15. These results demonstrate a unique induction of JUNB in response to kinase inhibitor therapies that may be among the earliest events in the progression to treatment resistance. PMID:24858691
16. Apoptosis rate of HepG2 cells transformed with pEGFP-C1-wtp53/JunB was significantly higher. PMID:23259178
17. Data demonstrate that S100A14 is transcriptionally regulated by JunB and involved in esophageal squamous cell carcinoma cell differentiation. PMID:24107296
18. an important role of the A2B receptor-dependent upregulation of JunB in VEGF production and possibly other AP-1-regulated events. PMID:24136993
19. JUNB was specifically expressed in human immune cells during acute liver injury. PMID:24200694
20. JunB is shown to be regulated at a post-transcriptional level during EC activation. In activated EC, the AP-1 transcription factor JunB, is regulated on a post-transcriptional level. PMID:23297064
21. JunB regulates visceral smooth muscle cell contractility through effects on both myosin and the actin cytoskeleton. PMID:23308222
22. A novel mechanism by which mitosis progression and chromatid cohesion are regulated through GSK3/SCF(FBXW7)-mediated proteolysis of JunB. PMID:22710716
23. Study confirmed that JunB was upregulated in VHL-defective clear-cell renal-cell carcinoma (ccRCC) specimens by immunostaining. Short-hairpin RNA (shRNA)-mediated knockdown of JunB in 786-O and A498 VHL null ccRCC cells suppressed their invasiveness. PMID:22020339
24. Different mechanisms preserve translation of programmed cell death 8 and JunB in poliovirus-infected endothelial cells. PMID:22328780
25. up-regulation of JunB induced by HGF might play an important role in the regulation of cell proliferation and cell invasion through MMP-9 expression. PMID:22252121
26. JunB activates aromatase promoters by maintaining JunD expression PMID:21393445
27. The methylation of JunB and CDH13 gene promoters probably plays a role in the pathogenesis of chronic myelogenous leukemia and may have clinical significance in predicting prognosis of CML. PMID:20030915
28. JunB is a direct transcriptional activator of GzB and that GzB transcription is also promoted by NPM-ALK. PMID:21326808
29. Monoammonium glycyrrhizinate highly stimulated JUNB expression in a human hepatoma cell line, HepG2. PMID:21225234
30. The increase in JunB expression attenuated nuclear relocation of apoptosis-inducing factor and mitochondrial Bcl-2 reduction that occurred following hydrogen peroxide exposure. PMID:20132737
31. JunB functions as a transcriptional factor and up-regulates the expression of VEGF. PMID:20056077
32. This analysis shows that the overwhelming majority of JUNB alleles in both chronic phase and blast crisis samples remain unmethylated PMID:20006998
33. When p53 dysfunction and low expression of JunB are simultaneous, they may play an important role in down-regulating the expression of KAI1 by synergism in hepatocellular carcinoma. PMID:19666408
34. JunB is an important regulator of erythroid differentiation PMID:11726656
35. JunB potentiates function of BRCA1 activation domain 1 (AD1) through a coiled-coil-mediated interaction PMID:12080089
36. demonstrated that a functional AP-1 site mediates MMP-2 transcription in cardiac cells through the binding of distinctive Fra1-JunB and FosB-JunB heterodimers. The synthesis of MMP-2 is considered to be independent of the AP-1 transcriptional complex PMID:12371906
37. results have revealed, for the first time, amplification and expression patterns of JUNB in primary cutaneous lymphomas PMID:12393503
38. Real-time RT-PCR gave further insights into the role of JunB in human CML. The expression levels were significantly impaired in CML cases. In the promoter area, most of the CpG sites were methylated only in CML cases. PMID:12506033
39. C/EBPalpha and PKC/delta affect expression of this gene and monocyte differentiation. PMID:12522006
40. Expression of junB was induced by TPA and Saikosaponin a during 30 min to 6 h of treatment. PMID:12592382
41. JunB was strongly expressed in T-cell lymphomas, but non-Hodgkin B-cell lymphomas do not or only weakly express JunB. PMID:12907453
42. Transcription factor c-Jun plays a principal role in down-regulation of mdr-1 expression and induction of apoptosis in salvicine-treated human MDR K562/A02 cells. PMID:12907627
43. The IGFBP3, hRas, JunB, Egr-1, Id1 and MIDA1 genes were up-regulated in psoriatic involved skin compared with uninvolved skin. PMID:16552541
44. 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole sensitivity-inducing factor (DSIF)- and NELF-mediated transcriptional pausing has a dual function in regulating immediate-early expression of the human junB gene. PMID:16880520
45. JunB and JunD contribute opposing effects; JunB activated whereas JunD repressed heme oxygenase-1 expression in human renal epithelial cells PMID:17204476
46. results suggest that HTLV-I HBZ-SP1- mediated sequestration of JunB to the HBZ-SP1 nuclear bodies may be causing the repression of JunB activity in vivo PMID:17306025
47. JunB is a critical target of mTOR and is translationally regulated in NPM-ALK-positive lymphomas. PMID:17690253
48. constitutive action of aberrantly expressed JunB on hypomethylated CD30 CpG islands of lymphocytes triggers CD30 induction and initiates activation of the JunB-CD30-JunB loop, essential to the pathogenesis of HL and ALCL PMID:17965727
49. JunB levels, which are high in S phase, drop during mid- to late G2 phase due to accelerated phosphorylation-dependent degradation by the proteasome, and are required for subsequent reduction of cyclin A2 levels in prometaphase PMID:18391017
50. sumoylation of JunB regulates its ability to induce cytokine gene transcription and likely plays a critical role in T cell activation. PMID:18424718

Show More

Hide All

HGNC: 6205

UNIGENE: Hs.25292

KEGG: hsa:3726

STRING: 9606.ENSP00000303315

OMIM: 165161